Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron J Turtle

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2019
ReplyDaniel W Lee, Elena Mead, Bianca D Santomasso, et al.
Blood|October 28, 2011
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsSeitaro Terakura, Tori N Yamamoto, Rebecca A Gardner, et al.
Blood|October 14, 2009
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unitJonathan A Gutman, Cameron J Turtle, Thomas J Manley, et al.
Blood Advances|October 8, 2020
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapyVictor A Chow, Ajay K Gopal, Jordan Gauthier, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2015
Susceptibility of commonly used ferritin assays to the classic hook effectPratistha Ranjitkar, Cameron J Turtle, Neil S Harris, et al.
The Journal of Experimental Medicine|March 18, 2009
Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupusZhenpeng Dai, Cameron J Turtle, Garrett C Booth, et al.
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset compositionStanley R Riddell, Daniel Sommermeyer, Carolina Berger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2013
HLA engineering of human pluripotent stem cellsLaura Riolobos, Roli K Hirata, Cameron J Turtle, et al.
Science Translational Medicine|September 3, 2010
Overlap and effective size of the human CD8+ T cell receptor repertoireHarlan S Robins, Santosh K Srivastava, Paulo V Campregher, et al.
Transfusion|February 8, 2019
Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignanciesSherilyn A Tuazon, Ang Li, Theodore Gooley, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2019
ReplyDaniel W Lee, Elena Mead, Bianca D Santomasso, et al.
Blood|October 28, 2011
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsSeitaro Terakura, Tori N Yamamoto, Rebecca A Gardner, et al.
Blood|October 14, 2009
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unitJonathan A Gutman, Cameron J Turtle, Thomas J Manley, et al.
Blood Advances|October 8, 2020
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapyVictor A Chow, Ajay K Gopal, Jordan Gauthier, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2015
Susceptibility of commonly used ferritin assays to the classic hook effectPratistha Ranjitkar, Cameron J Turtle, Neil S Harris, et al.
The Journal of Experimental Medicine|March 18, 2009
Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupusZhenpeng Dai, Cameron J Turtle, Garrett C Booth, et al.
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Adoptive therapy with chimeric antigen receptor-modified T cells of defined subset compositionStanley R Riddell, Daniel Sommermeyer, Carolina Berger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 1, 2013
HLA engineering of human pluripotent stem cellsLaura Riolobos, Roli K Hirata, Cameron J Turtle, et al.
Science Translational Medicine|September 3, 2010
Overlap and effective size of the human CD8+ T cell receptor repertoireHarlan S Robins, Santosh K Srivastava, Paulo V Campregher, et al.
Transfusion|February 8, 2019
Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignanciesSherilyn A Tuazon, Ang Li, Theodore Gooley, et al.
Pageof 13